Stay updated on ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial page.

Latest updates to the ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial page
- Check4 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', indicating enrollment is closed. The page also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and standardizes the Intervention/Treatment header, with the revision version updated to v3.6.0.SummaryDifference0.5%

- Check12 days agoChange DetectedRevision: v3.5.5 appears on the page, replacing the previous Revision: v3.5.4. This indicates a minor update to the page versioning or documentation without altering the study content.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page's revision tag was updated to v3.5.4, replacing v3.5.3 and signaling a newer release. This metadata update does not change the visible content or functionality of the page.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page’s displayed revision/version has been updated from **v3.5.2** to **v3.5.3**.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check90 days agoChange DetectedThe site revision label has been updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

Stay in the know with updates to ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial page.